RFPL3 and lung carcinoma: The results showed that CBP was found in all the lung cancer cell lines in the complexes pulled down by anti-RFPL3 antibody, but not found in the IgG-treated samples (Figure 2A), indicating that RFPL3 indeed interacted directly with CBP in the nucleus of lung cancer cell lines.